Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01393171 · ClinicalTrials.gov registry record · NA
Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT01393171: Completed NA study, sponsored by Kaiser Permanente.
NCT01393171 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01393171, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the success rate of cystocele repair using polypropylene mesh or porcine dermis compared to that of anterior colporrhaphy in a prospective randomized fashion. The study will be performed in a randomized, prospective, single-blinded fashion.
Primary Outcome
The primary outcome as the number of participants with optimal anterior vaginal support at two year defined as POPQ point Ba \< -1.
Interventions
- DEVICE Polypropylene mesh (Polyform by Boston Scientific)
- PROCEDURE Porcine Dermis (Pelvicol by CRBard)
- PROCEDURE Anterior Colporrhaphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2006-01 |
| Est. Completion | 2018-04-01 |
| Phase | NA |
What the finished NCT01393171 record still lists
NCT01393171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Polypropylene mesh (Polyform by Boston Scientific) is the first listed.
NCT01393171 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01393171 about?
NCT01393171 is a clinical study titled "Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis". The purpose of this study is to evaluate the success rate of cystocele repair using polypropylene mesh or porcine dermis compared to that of anterior colporrhaphy in a prospective randomized fashion. The study will be performed in a randomized, prospective, single-blinded fashion.
What is the current status of trial NCT01393171?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2006-01. Estimated completion is 2018-04-01.
What interventions are being tested in trial NCT01393171?
The interventions under investigation include: Polypropylene mesh (Polyform by Boston Scientific) (DEVICE), Porcine Dermis (Pelvicol by CRBard) (PROCEDURE), Anterior Colporrhaphy (PROCEDURE).
Who is sponsoring clinical trial NCT01393171?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01393171's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia